fda food and drug administration news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

Time on MSN · 3h

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

Investopedia on MSN · 3h

Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval

Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. We may earn a commission when you buy through links on our sites.

Salmonella and Listeria Found in 2 Pet Food Brands

YAHOO!News · 21h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

Salmonella and Listeria Found in 2 Pet Food Brands: Everything to Know

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 22h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 21h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 22h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

1h

FDA approves new type of schizophrenia drug

The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...

4h

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

16h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

1hon MSN

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results